Comment
doi: 10.1016/S1470-2045(18)30005-6.
Epub 2018 Jan 18.
A turning point in the fight against ovarian cancer?
Affiliations
- PMID: 29361471
- DOI: 10.1016/S1470-2045(18)30005-6
Item in Clipboard
Comment
A turning point in the fight against ovarian cancer?
Lancet Oncol.
2018 Feb.
No abstract available
Comment on
-
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study.Lancet Oncol. 2018 Feb;19(2):207-215. doi: 10.1016/S1470-2045(18)30009-3. Epub 2018 Jan 18. Lancet Oncol. 2018. PMID: 29361470 Free PMC article.
Similar articles
-
The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma.Clin Cancer Res. 2017 Aug 1;23(15):4354-4363. doi: 10.1158/1078-0432.CCR-16-2876. Epub 2017 Mar 7. Clin Cancer Res. 2017. PMID: 28270495
-
Checkpoint inhibitors in immunotherapy of ovarian cancer.Tumour Biol. 2015 Jan;36(1):33-9. doi: 10.1007/s13277-014-2848-2. Epub 2014 Nov 20. Tumour Biol. 2015. PMID: 25409618 Review.
-
Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints.Curr Med Chem. 2017;24(15):1504-1519. doi: 10.2174/0929867323666161205122613. Curr Med Chem. 2017. PMID: 27919216 Review.
-
Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.J Proteomics. 2017 Jan 16;151:2-11. doi: 10.1016/j.jprot.2016.06.009. Epub 2016 Jul 6. J Proteomics. 2017. PMID: 27394697
-
Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.Int J Mol Sci. 2015 Nov 13;16(11):27228-51. doi: 10.3390/ijms161126018. Int J Mol Sci. 2015. PMID: 26580601 Free PMC article.
Cited by
-
Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas.Cancers (Basel). 2020 May 21;12(5):1315. doi: 10.3390/cancers12051315. Cancers (Basel). 2020. PMID: 32455819 Free PMC article. Review.
-
Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer.Arch Gynecol Obstet. 2021 Mar;303(3):767-775. doi: 10.1007/s00404-020-05822-w. Epub 2020 Oct 3. Arch Gynecol Obstet. 2021. PMID: 33011886
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
